Visual impairment due to macular oedema: Added benefit of faricimab not proven in new study Dr. Kamal Kant Kohli31 Dec 2024 10:30 PM ISTSince July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein...
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
Faricimab reduces fluid in Neovascular Age-Related Macular Degeneration eyes, unravels study Dr Ishan Kataria12 Nov 2024 8:00 PM ISTAge-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 years old. ...
Faricimab therapy closely associated with severe intraocular inflammation, reveals research Jacinthlyn Sylvia16 Oct 2024 8:00 PM ISTA new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular inflammation may be...
Roche Vabysmo prefilled syringe bags USFDA nod for three causes of vision loss Ruchika Sharma6 July 2024 4:34 PM ISTVabysmo PFS delivers the same medicine as the currently available Vabysmo vials in an alternative, ready-to-use format.
Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion Ruchika Sharma29 Jun 2024 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Roche Pharma India forays into Ophthalmology space with launch of Vabysmo Ruchika Sharma6 March 2024 4:10 PM ISTAs the world's first bispecific antibody, Vabysmo is a single molecule designed to target and inhibit the effects of two targets, providing the...
Faricimab outperforms anti-VEGF Drugs in DME and AMD Treatment by improving central subfoveal thickness Aditi5 Jan 2024 10:45 PM ISTIn the industrialized world, Neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME) cause blindness. Faricimab, launched...
Roche gets CDSCO panel Nod To study safety, and efficacy of Faricimab Intravitreal injection Dr. Divya Colin29 Oct 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion Ruchika Sharma27 Oct 2023 11:32 AM IST"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...
Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche Ruchika Sharma10 Oct 2023 2:30 PM ISTBasel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...
USFDA accepts application for Roche Vabysmo for retinal vein occlusion treatment Ruchika Sharma9 May 2023 11:42 AM ISTRetinal vein occlusion is the second most common cause of vision loss due to retinal vascular diseases.
